A citation-based method for searching scientific literature

Robert P Carson, Nathaniel D Kelm, Kathryn L West, Mark D Does, Cary Fu, Grace Weaver, Eleanor McBrier, Brittany Parker, Mark D Grier, Kevin C Ess. Ann Clin Transl Neurol 2015
Times Cited: 41







List of co-cited articles
466 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.
Frédéric Lebrun-Julien, Lea Bachmann, Camilla Norrmén, Martin Trötzmüller, Harald Köfeler, Markus A Rüegg, Michael N Hall, Ueli Suter. J Neurosci 2014
111
51

A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival.
Lynsey Meikle, Delia M Talos, Hiroaki Onda, Kristen Pollizzi, Alexander Rotenberg, Mustafa Sahin, Frances E Jensen, David J Kwiatkowski. J Neurosci 2007
321
46

Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination.
Stacey E Wahl, Lauren E McLane, Kathryn K Bercury, Wendy B Macklin, Teresa L Wood. J Neurosci 2014
123
36

Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex.
Ebru Ercan, Juliette M Han, Alessia Di Nardo, Kellen Winden, Min-Joon Han, Leonie Hoyo, Afshin Saffari, Andrew Leask, Daniel H Geschwind, Mustafa Sahin. J Exp Med 2017
54
36

Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination.
Kathryn K Bercury, JinXiang Dai, Hilary H Sachs, Jared T Ahrendsen, Teresa L Wood, Wendy B Macklin. J Neurosci 2014
98
31

The tuberous sclerosis complex.
Peter B Crino, Katherine L Nathanson, Elizabeth Petri Henske. N Engl J Med 2006
26

Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.
Robert P Carson, Dominic L Van Nielen, Peggy A Winzenburger, Kevin C Ess. Neurobiol Dis 2012
110
26

Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation.
William A Tyler, Nitish Gangoli, Pradeepa Gokina, Haesun A Kim, Matthew Covey, Steven W Levison, Teresa L Wood. J Neurosci 2009
191
26

Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Ling-Hui Zeng, Lin Xu, David H Gutmann, Michael Wong. Ann Neurol 2008
430
26

Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.
Lynsey Meikle, Kristen Pollizzi, Anna Egnor, Ioannis Kramvis, Heidi Lane, Mustafa Sahin, David J Kwiatkowski. J Neurosci 2008
356
24

Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.
Erik J Uhlmann, Michael Wong, Rebecca L Baldwin, M Livia Bajenaru, Hiroaki Onda, David J Kwiatkowski, Kelvin Yamada, David H Gutmann. Ann Neurol 2002
268
24

Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes.
Minqing Jiang, Lei Liu, Xuelian He, Haibo Wang, Wensheng Lin, Huimin Wang, Sung O Yoon, Teresa L Wood, Q Richard Lu. Nat Commun 2016
39
25

Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex.
Jurriaan M Peters, Mustafa Sahin, Vanessa K Vogel-Farley, Shafali S Jeste, Charles A Nelson, Matthew C Gregas, Sanjay P Prabhu, Benoit Scherrer, Simon K Warfield. Acad Radiol 2012
83
21


Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.
S Priyadarshini Narayanan, Ana I Flores, Feng Wang, Wendy B Macklin. J Neurosci 2009
241
21

mTOR Signaling in Growth, Metabolism, and Disease.
Robert A Saxton, David M Sabatini. Cell 2017
21


mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
19

The neurology of mTOR.
Jonathan O Lipton, Mustafa Sahin. Neuron 2014
388
19

Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.
Sharon W Way, James McKenna, Ulrike Mietzsch, R Michelle Reith, Henry Cheng-Ju Wu, Michael J Gambello. Hum Mol Genet 2009
142
19

Myelination and mTOR.
Gianluca Figlia, Daniel Gerber, Ueli Suter. Glia 2018
75
19

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
Jacqueline A French, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, Dennis J Dlugos, Noah Berkowitz,[...]. Lancet 2016
333
19

Everolimus alters white matter diffusion in tuberous sclerosis complex.
Jan-Mendelt Tillema, James L Leach, Darcy A Krueger, David Neal Franz. Neurology 2012
57
17

Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex.
Leah Marcotte, Eleonora Aronica, Marianna Baybis, Peter B Crino. Acta Neuropathol 2012
55
17

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
Ken Inoki, Yong Li, Tian Xu, Kun-Liang Guan. Genes Dev 2003
17

Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Ling-Hui Zeng, Nicholas R Rensing, Bo Zhang, David H Gutmann, Michael J Gambello, Michael Wong. Hum Mol Genet 2011
155
17

Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model.
Nils Grabole, Jitao David Zhang, Stefan Aigner, Nadine Ruderisch, Veronica Costa, Felix C Weber, Michel Theron, Nikolaos Berntenis, Olivia Spleiss, Martin Ebeling,[...]. Genome Med 2016
25
28

mTORC1 controls PNS myelination along the mTORC1-RXRγ-SREBP-lipid biosynthesis axis in Schwann cells.
Camilla Norrmén, Gianluca Figlia, Frédéric Lebrun-Julien, Jorge A Pereira, Martin Trötzmüller, Harald C Köfeler, Ville Rantanen, Carsten Wessig, Anne-Lieke F van Deijk, August B Smit,[...]. Cell Rep 2014
78
14

Oligodendrocyte precursor cell-intrinsic effect of Rheb1 controls differentiation and mediates mTORC1-dependent myelination in brain.
Yi Zou, Wanxiang Jiang, Jianqing Wang, Zhongping Li, Junyan Zhang, Jicheng Bu, Jia Zou, Liang Zhou, Shouyang Yu, Yiyuan Cui,[...]. J Neurosci 2014
44
14

Constitutively active Akt induces enhanced myelination in the CNS.
Ana I Flores, S Priyadarshini Narayanan, Emily N Morse, H Elizabeth Shick, Xinghua Yin, Grahame Kidd, Robin L Avila, Daniel A Kirschner, Wendy B Macklin. J Neurosci 2008
265
14

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
Dan Ehninger, Sangyeul Han, Carrie Shilyansky, Yu Zhou, Weidong Li, David J Kwiatkowski, Vijaya Ramesh, Alcino J Silva. Nat Med 2008
586
14

Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
Emily P Harrington, Chao Zhao, Stephen P J Fancy, Sovann Kaing, Robin J M Franklin, David H Rowitch. Ann Neurol 2010
125
14

Tuberous sclerosis complex proteins control axon formation.
Yong-Jin Choi, Alessia Di Nardo, Ioannis Kramvis, Lynsey Meikle, David J Kwiatkowski, Mustafa Sahin, Xi He. Genes Dev 2008
190
14

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.
Dos D Sarbassov, Siraj M Ali, Shomit Sengupta, Joon-Ho Sheen, Peggy P Hsu, Alex F Bagley, Andrew L Markhard, David M Sabatini. Mol Cell 2006
14

Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
Theresa Scholl, Angelika Mühlebner, Gerda Ricken, Victoria Gruber, Anna Fabing, Sharon Samueli, Gudrun Gröppel, Christian Dorfer, Thomas Czech, Johannes A Hainfellner,[...]. Brain Pathol 2017
35
17


Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
Lauren E McLane, Jennifer N Bourne, Angelina V Evangelou, Luipa Khandker, Wendy B Macklin, Teresa L Wood. J Neurosci 2017
15
40

Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.
Karin Boer, Dirk Troost, Floor Jansen, Mark Nellist, Ans M W van den Ouweland, Jeroen J G Geurts, Wim G M Spliet, Peter Crino, Eleonora Aronica. Neuropathology 2008
74
14

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.
Laura Magri, Marco Cambiaghi, Manuela Cominelli, Clara Alfaro-Cervello, Marco Cursi, Mauro Pala, Alessandro Bulfone, Jose Manuel Garcìa-Verdugo, Letizia Leocani, Fabio Minicucci,[...]. Cell Stem Cell 2011
169
14

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis.
Veronica Costa, Stefan Aigner, Mirko Vukcevic, Evelyn Sauter, Katharina Behr, Martin Ebeling, Tom Dunkley, Arno Friedlein, Sannah Zoffmann, Claas A Meyer,[...]. Cell Rep 2016
59
14

Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.
Guomei Tang, Kathryn Gudsnuk, Sheng-Han Kuo, Marisa L Cotrina, Gorazd Rosoklija, Alexander Sosunov, Mark S Sonders, Ellen Kanter, Candace Castagna, Ai Yamamoto,[...]. Neuron 2014
575
14

Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.
Véronique Ruppe, Pelin Dilsiz, Carol Shoshkes Reiss, Chad Carlson, Orrin Devinsky, David Zagzag, Howard L Weiner, Delia M Talos. Epilepsia 2014
64
14

Diffusion tensor imaging of commissural and projection white matter in tuberous sclerosis complex and correlation with tuber load.
G Simao, C Raybaud, S Chuang, C Go, O C Snead, Elysa Widjaja. AJNR Am J Neuroradiol 2010
33
15

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
Darcy A Krueger, Marguerite M Care, Katherine Holland, Karen Agricola, Cynthia Tudor, Prajakta Mangeshkar, Kimberly A Wilson, Anna Byars, Tarek Sahmoud, David Neal Franz. N Engl J Med 2010
654
12

Diffusion features of white matter in tuberous sclerosis with tractography.
Michelle L Krishnan, Olivier Commowick, Shafali S Jeste, Neil Weisenfeld, Arne Hans, Matthew C Gregas, Mustafa Sahin, Simon K Warfield. Pediatr Neurol 2010
46
12

Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.
Alessia Di Nardo, Mary H Wertz, Erica Kwiatkowski, Peter T Tsai, Jarrett D Leech, Emily Greene-Colozzi, June Goto, Pelin Dilsiz, Delia M Talos, Clary B Clish,[...]. Hum Mol Genet 2014
68
12

The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.
Jingxiang Huang, Brendan D Manning. Biochem J 2008
817
12

Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway.
Jacek Jaworski, Samantha Spangler, Daniel P Seeburg, Casper C Hoogenraad, Morgan Sheng. J Neurosci 2005
443
12

Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders.
William W Lewis, Mustafa Sahin, Benoit Scherrer, Jurriaan M Peters, Ralph O Suarez, Vanessa K Vogel-Farley, Shafali S Jeste, Matthew C Gregas, Sanjay P Prabhu, Charles A Nelson,[...]. Cereb Cortex 2013
46
12

Brain abnormalities in tuberous sclerosis complex.
Francis J DiMario. J Child Neurol 2004
113
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.